Literature DB >> 26092968

Influence of the A118G Polymorphism of the OPRM1 Gene and Exon 3 VNTR Polymorphism of the DRD4 Gene on Cigarette Craving After Alcohol Administration.

William V Lechner1, Valerie S Knopik2, John E McGeary2, Nichea S Spillane3, Jennifer W Tidey3, Sherry A McKee4, Jane Metrik5, Adam M Leventhal6, Damaris J Rohsenow5, Christopher W Kahler3.   

Abstract

INTRODUCTION: The current study examined whether the presence of the G allele of the A118G polymorphism of the OPRM1 gene (rs1799971) and the long allele of exon 3 VNTR polymorphism of the DRD4 gene moderate the effect of alcohol administration on urge to smoke. These polymorphisms have been associated with greater alcohol induced-urge to drink. Urge to drink and alcohol consumption increase urge to smoke. Therefore, these polymorphisms may also sensitize urge to smoke after alcohol consumption.
METHODS: Individuals smoking 10-30 cigarettes per day and reporting heavy drinking were recruited from the community. Caucasians (n = 62), 57.3% male, mean age 39.2, took part in a three-session, within-subjects, repeated-measures design study. Participants were administered a placebo, 0.4 g/kg, or 0.8 g/kg dose of alcohol. A118G genotype, exon 3 VNTR genotype, and urge to smoke (baseline and three times after receiving alcohol) were assessed.
RESULTS: G allele carriers showed greater urge to smoke across all assessments. Additionally, a significant interaction indicated that G carriers, compared to homozygotes (AA), evinced a significantly greater increase in urge to smoke after high dose alcohol relative to placebo. The interaction between condition, DRD4 polymorphism, and time was not significant.
CONCLUSIONS: Presence of G allele of the A118G polymorphism of the OPRM1 gene may lead to greater increases in urge to smoke after a high dose of alcohol. Pharmacotherapies targeted to opiate receptors (eg, naltrexone) may be especially helpful in aiding smoking cessation among G carriers who are heavy drinkers.
© The Author 2015. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26092968      PMCID: PMC5896808          DOI: 10.1093/ntr/ntv136

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  34 in total

1.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings.

Authors:  L S Cox; S T Tiffany; A G Christen
Journal:  Nicotine Tob Res       Date:  2001-02       Impact factor: 4.244

2.  Alcohol use and initial smoking lapses among heavy drinkers in smoking cessation treatment.

Authors:  Christopher W Kahler; Nichea S Spillane; Jane Metrik
Journal:  Nicotine Tob Res       Date:  2010-05-27       Impact factor: 4.244

3.  Exact tests for Hardy-Weinberg proportions.

Authors:  William R Engels
Journal:  Genetics       Date:  2009-09-21       Impact factor: 4.562

4.  OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors in rhesus macaques.

Authors:  Melanie L Schwandt; Stephen G Lindell; James D Higley; Stephen J Suomi; Markus Heilig; Christina S Barr
Journal:  Psychoneuroendocrinology       Date:  2011-04-03       Impact factor: 4.905

5.  A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans.

Authors:  Lara A Ray; Kent E Hutchison
Journal:  Alcohol Clin Exp Res       Date:  2004-12       Impact factor: 3.455

6.  Length of smoking deprivation moderates the effects of alcohol administration on urge to smoke.

Authors:  Anne M Day; Christopher W Kahler; Nichea S Spillane; Jane Metrik; Damaris J Rohsenow
Journal:  Addict Behav       Date:  2014-02-06       Impact factor: 3.913

7.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

8.  Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus.

Authors:  Christina S Barr; Scott A Chen; Melanie L Schwandt; Stephen G Lindell; Hui Sun; Stephen J Suomi; Markus Heilig
Journal:  Biol Psychiatry       Date:  2010-01-01       Impact factor: 13.382

9.  An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Daniel E Falk; Hsiao-ye Yi; Susanne Hiller-Sturmhöfel
Journal:  Alcohol Res Health       Date:  2006

Review 10.  Epidemiologic analysis of alcohol and tobacco use.

Authors:  J C Anthony; F Echeagaray-Wagner
Journal:  Alcohol Res Health       Date:  2000
View more
  2 in total

1.  Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial.

Authors:  Daniel J O Roche; Constantine J Trela; Maria Argos; Farzana Jasmine; Muhammad G Kibriya; Habibul Ahsan; Andrea C King
Journal:  Alcohol Alcohol       Date:  2019-01-09       Impact factor: 3.913

2.  The frequency of DRD2 rs1076560 and OPRM1 rs1799971 in substance use disorder patients from the United Arab Emirates.

Authors:  Hiba Alblooshi; Gary Hulse; Wael Osman; Ahmed El Kashef; Mansour Shawky; Hamad Al Ghaferi; Habiba Al Safar; Guan K Tay
Journal:  Ann Gen Psychiatry       Date:  2018-06-01       Impact factor: 3.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.